Travoprost Ophthalmic Solution
Product Images NDC 71335-2888

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Travoprost Ophthalmic (NDC 71335-2888). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Extended Label (713352888 Extendedlabel)

This is a list of inactive ingredients found in a pharmaceutical product. These include polyoxyl 40 hydrogenated castor oil, boric acid, propylene glycol, sorbitol, zinc chloride, sodium hydroxide (and/or hydrochloric acid for pH adjustment), and water for Injection USP.*

FDA Label Image

Label (Lbl713352888)

Each milliliter of the solution contains 0.04 mg of the active ingredient, Travoprost. The usual dosage recommended is one drop in the affected eye(s) every evening. The bottle is not child-resistant and should be kept out of reach of children. The solution is preserved with an ionic buffered system. It is advised to store the product at a temperature between 2° to 25°C. The solution is for ophthalmic use only and was relabeled by Bryant Ranch Prepack, Inc. and manufactured by Micro Labs Limited in Burbank, CA, USA. More information can be obtained by scanning the package insert QR code.*

FDA Label Image

Travoprost-figa.jpg (Travoprost Figa)

FDA Label Image

Travoprost-figb.jpg (Travoprost Figb)

FDA Label Image

Travoprost-figc.jpg (Travoprost Figc)

FDA Label Image

Travoprost-str.jpg (Travoprost Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.